Effect of zinc in treatment of gestational diabetes

Phase 3

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; O24.9

• Registration Number: IRCT201408295623N26
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 58

Inclusion Criteria

Inclusion Criteria: Pregnant women aged 18-40 years diagnosed with gestational diabetes mellitus at 24-28 weeks' gestation

Exclusion Criteria

Taking zinc supplements
Premature preterm rupture of membrane
Placenta abruption
Pre-eclampsia
Eclampsia
Chronic hypo- and hypothyroidism
The use of substitute treatments including hormone or vitamin supplements
Complete bed rest (CBR)
Intra uterine fetal death (IUFD)
Preterm delivery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Eliza.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation with HOMA formula.;Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Eliza.;Newborns PPAR-gamma. Timepoint: Cord blood of newborns of women with GDM at delivery time. Method of measurement: PCR-RT.